Current treatment of follicular low-grade lymphomas

Keyphrases

• Lymphoma 100%
• Therapeutic Intervention 100%
• Current Treatment 100%
• Follicular Lymphoma 100%
• Low-grade Lymphoma 100%
• United States 50%
• Phase II Trial 50%
• Clinical Course 50%
• Bone Marrow 50%
• Initial Treatment 50%
• Remission 50%
• Combination Chemotherapy 50%
• Advanced Stage 50%
• Complete Remission 50%
• Life Expectancy 50%
• Cytotoxic Drugs 50%
• Complete Response Rate 50%
• Overall Response Rate 50%
• Indolent non-Hodgkin Lymphoma 50%
• Phase number 50%
• Multiple Attempts 50%
• Recombinant Interferon 50%
• Treatment Intensity 50%
• Median Life 50%
• Differential Benefits 50%
• Working Diagnosis 50%

Medicine and Dentistry

• Non-Hodgkin Lymphoma 100%
• Follicular Lymphoma 66%
• Disease Course 33%
• Life Expectancy 33%
• Combination Chemotherapy 33%
• Phase III and IV Trials 33%
• Recombinant Interferon 33%
• Immunologic Agent 33%
• Cytotoxic Agent 33%